Live Earnings Conference Call: Astrana Health will host a live Q2 2025 earnings call on August 7, 2025 at 5:30PM ET. Follow this link to get details and listen to Astrana Health's Q2 2025 earnings call when it goes live. Get details. NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $21.81 -0.51 (-2.28%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$29.76 +7.95 (+36.43%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Astrana Health Stock (NASDAQ:ASTH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Astrana Health alerts:Sign Up Key Stats Today's Range$21.36▼$22.3650-Day Range$21.57▼$26.7052-Week Range$21.36▼$63.20Volume343,885 shsAverage Volume352,068 shsMarket Capitalization$1.22 billionP/E Ratio30.29Dividend YieldN/APrice Target$53.29Consensus RatingModerate Buy Company Overview Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California. Read More Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreASTH MarketRank™: Astrana Health scored higher than 69% of companies evaluated by MarketBeat, and ranked 304th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageAstrana Health has received no research coverage in the past 90 days.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth22.61% Earnings GrowthEarnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 30.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.49.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 30.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.41.Price to Earnings Growth RatioAstrana Health has a PEG Ratio of 0.82. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.12% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Astrana Health has recently increased by 6.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.12% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Astrana Health has recently increased by 6.99%, indicating that investor sentiment is decreasing significantly. News and Social Media1.9 / 5News Sentiment0.44 News SentimentAstrana Health has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Astrana Health this week, compared to 5 articles on an average week.Search InterestOnly 3 people have searched for ASTH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Astrana Health to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by Insiders20.00% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Email Address ASTH Stock News HeadlinesAstrana Health (ASTH) Receives a Buy from TD CowenJuly 29, 2025 | theglobeandmail.comHead to Head Analysis: Chemed (NYSE:CHE) and Astrana Health (NASDAQ:ASTH)July 29, 2025 | americanbankingnews.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.August 7 at 2:00 AM | Brownstone Research (Ad)Astrana Health Inc. Research & Ratings | ASTH - Barron'sJuly 26, 2025 | barrons.comAre Astrana Health, Inc.'s (NASDAQ:ASTH) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?July 25, 2025 | finance.yahoo.comAstrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference CallJuly 22, 2025 | prnewswire.comAnalysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and Centene (CNC)July 13, 2025 | theglobeandmail.comAll You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade ...July 12, 2025 | finance.yahoo.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $31.53 at the beginning of the year. Since then, ASTH stock has decreased by 30.8% and is now trading at $21.81. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) announced its earnings results on Thursday, May, 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by $0.09. The company's revenue for the quarter was up 53.4% on a year-over-year basis. Read the conference call transcript. Who are Astrana Health's major shareholders? Astrana Health's top institutional investors include SteelPeak Wealth LLC (0.96%), Bank of New York Mellon Corp (0.45%), Hussman Strategic Advisors Inc. (0.22%) and Westmount Partners LLC (0.15%). How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Astrana Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings5/08/2025Today8/07/2025Next Earnings (Estimated)8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryBusiness Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.apollomed.net Phone626-282-0288Fax818-839-5190Employees1,900Year FoundedN/APrice Target and Rating Average Price Target for Astrana Health$53.29 High Price Target$70.00 Low Price Target$36.00 Potential Upside/Downside+144.3%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.72 Trailing P/E Ratio30.29 Forward P/E Ratio18.97 P/E Growth0.82Net Income$43.15 million Net Margins1.56% Pretax Margin2.95% Return on Equity4.90% Return on Assets2.68% Debt Debt-to-Equity Ratio0.54 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$2.03 billion Price / Sales0.60 Cash Flow$1.45 per share Price / Cash Flow15.04 Book Value$14.59 per share Price / Book1.49Miscellaneous Outstanding Shares56,060,000Free Float44,850,000Market Cap$1.22 billion OptionableOptionable Beta0.85 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:ASTH) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.